RPC Pharma Ltd 13D and 13G filings for Akari Therapeutics, Plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-10-20 5:00 pm Purchase |
2023-10-06 | 13D | Akari Therapeutics, Plc AKTX |
RPC Pharma Ltd | 2,537,089,900 21.800% |
2,422,344,655 (+2111.06%) |
Filing |
| 2023-04-14 4:06 pm Purchase |
2023-03-31 | 13D | Akari Therapeutics, Plc AKTX |
RPC Pharma Ltd | 114,745,245 22.700% |
68,037,935 (+145.67%) |
Filing |
| 2022-01-14 4:18 pm Purchase |
2021-12-29 | 13D | Akari Therapeutics, Plc AKTX |
RPC Pharma Ltd | 46,707,310 18.000% |
2,022,975 (+4.53%) |
Filing |
| 2021-10-18 5:06 pm Purchase |
2021-07-07 | 13D | Akari Therapeutics, Plc AKTX |
RPC Pharma Ltd | 44,684,335 18.800% |
3,060,480 (+7.35%) |
Filing |